News

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50, down from 60, following ...
The Food and Drug Administration has approved three vaccines for RSV — GSK's GSK.L Arexvy, Moderna's MRNA.O mRESVIA and ...
Three simultaneous withdrawals—from the World Health Organization, USAID and the Gavi vaccine alliance—represent a ...
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Shares of Moderna MRNA rose nearly 6% yesterday after the U.S. Centers for Disease Control and Prevention (“CDC”) adopted new ...
The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
A Pa. lawmaker is trying to prevent lapses in insurance coverage for vaccines, even if key advisers in the CDC change their ...
The new vaccine committee appointed by Secretary Robert F. Kennedy Jr. took minimal action in its first meeting.
The U.S. Centers for Disease Control and Prevention has accepted recommendations made by an advisory panel in April on the ...
The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...